Literature DB >> 12719462

The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a French-Italian multicentre study.

E Tonutti1, D Visentini, N Bizzaro, M Caradonna, L Cerni, D Villalta, R Tozzoli.   

Abstract

AIMS: Tissue transglutaminase (tTG) was recently identified as the major autoantigen in coeliac disease. The aim of this multicentre study was to evaluate the impact of a new immunoenzymatic assay for the detection of IgA anti-tGT antibodies.
METHODS: Seventy four Italian and French clinical laboratories participated in this study; anti-tTG IgA with an enzyme linked immunosorbent assay (ELISA) method using guinea pig liver extract as the coating antigen, anti-endomysium IgA autoantibodies (EMA), and total serum IgA were determined in 7948 patients, 1162 of whom had coeliac disease (737 untreated cases and 425 on a gluten free diet). A proportion of the sera were then sent to a reference laboratory for anti-tTG retesting with an ELISA method using recombinant human tTG antigen.
RESULTS: Seven thousand four hundred and fifty eight (93.8%) sera were EMA/antiguinea pig tTG concordant (positive or negative); 490 (6.2%) were non-concordant. The sensitivity of EMA and antiguinea pig tTG in the 737 untreated patients with coeliac disease was 92.1% and 94.8%, respectively, and the specificity was 99.8% and 99.2%, respectively. Retesting of the discordant sera showed that of the 162 sera classified as EMA negative/antiguinea pig tTG positive, only 49 were positive for human recombinant anti-tTG, and that 39 of these were also EMA positive. Furthermore, of the 36 sera classified as EMA positive/antiguinea pig tTG negative, only two were confirmed as EMA positive.
CONCLUSIONS: The antiguinea pig tTG assay is more sensitive but less specific than EMA, whereas the antihuman recombinant tTG assay is far more specific and just as sensitive as antiguinea pig tTG. Testing for EMA presents considerable interpretative problems and is difficult to standardise.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719462      PMCID: PMC1769943          DOI: 10.1136/jcp.56.5.389

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  39 in total

Review 1.  The controversial epidemiology of coeliac disease.

Authors:  R Troncone; L Greco; S Auricchio
Journal:  Acta Paediatr       Date:  2000-02       Impact factor: 2.299

2.  Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening.

Authors:  S Riestra; E Fernández; L Rodrigo; S Garcia; G Ocio
Journal:  Scand J Gastroenterol       Date:  2000-04       Impact factor: 2.423

3.  Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study.

Authors:  J A Murray; J Herlein; F Mitros; J A Goeken
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  The prevalence of celiac disease in at-risk groups of children in the United States.

Authors:  I Hill; A Fasano; R Schwartz; D Counts; M Glock; K Horvath
Journal:  J Pediatr       Date:  2000-01       Impact factor: 4.406

5.  Epidemic of coeliac disease in Swedish children.

Authors:  A Ivarsson; L A Persson; L Nyström; H Ascher; B Cavell; L Danielsson; A Dannaeus; T Lindberg; B Lindquist; L Stenhammar; O Hernell
Journal:  Acta Paediatr       Date:  2000-02       Impact factor: 2.299

6.  Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease.

Authors:  T Hansson; I Dahlbom; J Hall; A Holtz; L Elfman; A Dannaeus; L Klareskog
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-04       Impact factor: 2.839

Review 7.  New diagnostic findings in coeliac disease.

Authors:  P Collin
Journal:  Ann Med       Date:  1999-12       Impact factor: 4.709

8.  Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy.

Authors:  M Sárdy; U Odenthal; S Kárpáti; M Paulsson; N Smyth
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

9.  Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery.

Authors:  W Dickey; D F Hughes; S A McMillan
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

10.  IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy.

Authors:  R J Lock; M C Pitcher; D J Unsworth
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

View more
  17 in total

Review 1.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

2.  Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.

Authors:  Umberto Volta; Alessandro Granito; Erica Fiorini; Claudia Parisi; Maria Piscaglia; Georgios Pappas; Paolo Muratori; Francesco B Bianchi
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

3.  Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.

Authors:  Elio Tonutti; Daniela Visentini; Alessia Picierno; Nicola Bizzaro; Danilo Villalta; Renato Tozzoli; Graziano Kodermaz; Antonio Carroccio; Giuseppe Iacono; Saverio Teresi; Stella Maria La Chiusa; Ignazio Brusca
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 4.  Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity.

Authors:  David Armstrong; Andrew C Don-Wauchope; Elena F Verdu
Journal:  Can J Gastroenterol       Date:  2011-04       Impact factor: 3.522

Review 5.  Serum markers in the clinical management of celiac disease.

Authors:  Marlou Adriaanse; Daniel A Leffler
Journal:  Dig Dis       Date:  2015-04-22       Impact factor: 2.404

6.  Investigation into celiac disease in Indian patients with portal hypertension.

Authors:  Rakhi Maiwall; Ashish Goel; Anna B Pulimood; Sudhir Babji; J Sophia; Chaya Prasad; K A Balasubramanian; Banumathi Ramakrishna; Susy Kurian; G John Fletcher; Priya Abraham; Gagandeep Kang; B S Ramakrishna; Elwyn Elias; C E Eapen
Journal:  Indian J Gastroenterol       Date:  2014-09-18

7.  Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis.

Authors:  N Bizzaro; M Tampoia; D Villalta; S Platzgummer; M Liguori; R Tozzoli; E Tonutti
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

8.  Assessment of a Test for the Screening and Diagnosis of Celiac Disease.

Authors:  Brunetta Porcelli; Fabio Ferretti; Carla Vindigni; Lucia Terzuoli
Journal:  J Clin Lab Anal       Date:  2014-11-10       Impact factor: 2.352

9.  Prevalence of celiac disease in Shiraz, southern Iran.

Authors:  Mehdi Saberi-Firouzi; Gholamhossein R Omrani; Marzieh Nejabat; Davood Mehrabani; Farnaz Khademolhosseini
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

10.  IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis.

Authors:  N Bizzaro; D Villalta; E Tonutti; A Doria; M Tampoia; D Bassetti; R Tozzoli
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.